Burden of human papillomavirus infection and related comorbidities in men: Implications for research, disease prevention and health promotion among hispanic men

Puerto Rico Health Sciences Journal

Volumn 29, Issue 3, 2010, Pages 232-240

  Colón López, Vivian ^a   Ortiz, Ana P ^a   Palefsky, Joel ^b  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anal cancer; Hispanics; HPV infection; Men; Penile cancer; Puerto Rico

Indexed keywords

COST OF ILLNESS; HEALTH PROMOTION; HISPANIC; HUMAN; MALE; MEDICAL RESEARCH; NEOPLASM; PAPILLOMAVIRUS INFECTION; PSYCHOLOGICAL ASPECT; REVIEW; VIROLOGY;

BIOMEDICAL RESEARCH; COST OF ILLNESS; HEALTH PROMOTION; HISPANIC AMERICANS; HUMANS; MALE; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS;

EID: 77957002485     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Pagano JS, Blaser M, Buendia MA, Damania B, et al. Infectious agents and cancer: Criteria for a causal relation. Semin Cancer Biol 2004;14: 453-471.
2. Pagliusi S. Vaccines against Human Papillomavirus. World Health Organization. Retrieved January 25, 2009 from the World Wide Web: http: // www.who.int/vaccines/en/hpvrd.shtml
3. Steben M, Duarte-Franco E. Human papillomavirus infection: Epidemiology and pathophysiology. Gynecol Oncol 2007; 107: S2-S5.
4. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36: 6-10.
5. Gerberding JL. Report to Congress: Prevention of Genital Human Papillomavirus Infection: Centers for Disease Control and Prevention. 2004, Center for Disease Control and Prevention. Retrieved November 11, 2008 from the World Wide Web: http: //www.cdc.gov/std/ HPV/2004HPV%20report.pdf
6. Hu D, Goldie S. The economic burden of noncervical human papillomavirus disease in the United States. Am J Obstet Gynecol 2008;198: 500 e1-7.
7. National Cancer Institute. Human Papillomaviruses and Cancer: Questions and Answer Factsheet. Available at: http: //www.cancer.gov/cancertopics/ factsheet/Risk/HPV
8. Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics 2009;12: 291-307.
9. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-3044.
10. Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008; 19: K17-K28.
11. Giuliano AR, Anic G, Nyitray AG. Epidemiology and Pathology of HPV disease in males. Gyn Oncology 2010;117: S15-S19.
12. Palefsky, JM. HPV infection in men. Dis Markers 2007; 23: 261-272.
13. Centers for Disease Control and Prevention. "HIV/AIDS Among Hispanics/ Latinos: Factsheet". Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. http: //www. cdc.gov/hiv/hispanics/resources/ factsheets/hispanic.htm.
14. Aral SO. Sexually transmitted diseases: Magnitude, determinants and consequences. Int J STD AIDS 2001;12: 211-215.
15. Cavazos-Rehg PA, Krauss MJ, Spitznagel EL, Schootman M, et al. Age of sexual debut among US adolescents. Contraception 2009; 80: 158-162.
16. Ortiz AP, Soto-Salgado M, Calo WA, Tortolero-Luna G, et al. Incidence and mortality rates of selected infection-related cancers in Puerto Rico and in the United States of America. Infect Agent Cancer 2010;14;5-10.
17. Ortiz Ortiz KJ, Irizarry P, Marín Centeno H, Ortiz AP, et al. Productivity Loss in Puerto Rico's Labor Market due to Cancer Mortality. PRHSJ 2010;3: 241-249.
18. Dunne EF, Nielson CM, Stone KM, Markowitz LE, et al.Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006;194: 1044-1057.
19. Palefsky JM. Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health 2010; 46: S12-S19.
20. Schiller JT, Castellsagué X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine 2008;26S: K53-K61.
21. Giuliano AR. Human papillomavirus vaccination in males. Gynecol Oncol 2007; 107: S24-S26.
22. Ireland JA, Reid M, Powell R, Petrie KJ. The role of illness perceptions: Psychological distress and treatment-seeking delay in patients with genital warts. Int J STD AIDS 2005;16: 667-670.
23. Dinh TH, Sternberg M, Dunne EF, Markowitz LE.Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999--2004. Sex Transm Dis 2008;35: 357-360.
24. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006; 24: S11-S25.
25. Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A, et al. Burden of invasive squamous cell carcinoma of the penis in the United States,1998-2003. Cancer 2008; 113: 2883-2891.
26. Franceschi S, Castellsagué X, Dal Maso L, Smith JS, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002; 86: 705-711.
27. Giuliano AR, Lazcano E, Villa LL, Flores R, et al. Circumcision and sexual behavior: Factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer 2009;124: 1251-1257.
28. Lajous, M, Mueller N, Cruz-Valdéz A, Aguilar LV,et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005;14: 1710-1716.
29. Nielson CM, Harris RB, Flores R, Abrahamsen M, et al. Multiple-type human papillomavirus infection in male anogenital sites: Prevalence and associated factors. Cancer Epidemiol Biomarkers Prev 2009;18: 1077-1083.
30. Vaccarella S, Lazcano-Ponce E, Castro-Garduño JA, Cruz-Valdez A, et al. Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer 2006;119: 1934-1939.
31. Lazcano-Ponce E, Herrero R, Muñoz N, Hernandez-Avila M, et al. High Prevalence of Human Papillomavirus Infection in Mexican Males. Comparative Study of Penile Urethral Swabs and Urine Samples. Sexually Transmitted Diseases 2001; 28: 277-280.
32. Baldwin, SB, Wallace DR, Papenfuss MR, Abrahamsen M, et al. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003;187: 1064-1070.
33. Castellsagué X, Bosch FX, Muñoz N, Meijer CJ, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346: 1105-1112.
34. Castellsagué X, Ghaffari A, Daniel RW, Bosch FX, et al. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997; 176: 353-361.
35. Svare EI, Kjaer SK, Worm AM, Osterlind A, et al. Risk factors for genital HPV DNA in men resemble those found in women: A study of male attendees at a Danish STD clinic. Sex Transm Infect 2002; 78: 215-218.
36. Castellsague X, Ghaffari A, Daniel RW, Bosch FX, et al. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: A study in Spain and Colombia. J Infect Dis 1997;176: 353-361.
37. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, et al. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis 2004; 31: 601-607.
38. Doherty IA, Padian NS, Marlow C, Aral SO. Determinants and consequences of sexual networks as they affect the spread of sexually transmitted infections. J Infect Dis 2005; 191: S42-54.
39. Giuliano AR, Lazcano E, Villa LL, Flores R, et al. Circumcision and sexual behavior: Factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer 2009;124: 1251-1257.
40. Xu F, Markowitz LE, Sternberg MR, Aral SO. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: The National Health and Nutrition Examination Survey (NHANES), 1999- 2004. Sex Transm Dis 2007; 34: 479-484.
41. Ortiz AP, Pérez CM. Sexual behaviors among a population-based sample of Puerto Rican Adults: Results from the Epidemiology of Hepatitis C (HCV) in the household, adult population of Puerto Rico study. 2009. Unpublished data.
42. Hernandez BY, Shvetsov YB, Goodman MT, Wilkens LR, et al. Reduced clearance of penile human papillomavirus infection in uncircumcised men. J Infect Dis 2010;201: 1340-1343.
43. Lu B, Wu Y, Nielson CM, Flores R, et al. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: A prospective study. J Infect Dis 2009;199: 362-371.
44. Palefsky J, HPV-Related Disease in Men: Anal and Penile Cancer, in Reducing the Global Burden of HPV-Related Disease: Cervical Cancer and Beyond. 2007. Retrieved from World Wide Web: http: //ww w.medscape. com/viewarticle/565225.
45. Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano A. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998- 2003. Cancer 2008;113: 2883-2891.
46. Puerto Rico Central Cancer Registry. Puerto Rico Comprehensive Cancer Center. University of Puerto Rico. Date release: February 11, 2009.
47. de Pokomandy A, Rouleau D, Ghattas G, Vézina S, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: The HIPVIRG cohort study. J Infect Dis 2009;199: 965-973.
48. Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, et al. Age-related prevalence of anal cancer precursors in homosexual men: The EXPLORE study. J Natl Cancer Inst 2005;97: 896-905.
49. Palefsky J, Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS 2009; 4: 52-56.
50. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002; 35: 1127-1134.
51. Palefsky JM, Holly EA, Ralston ML, Arthur SP, et al. Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin Med 1997; 73: 174-180.
52. Centers for Disease Control and Prevention. (2007). HIV/AIDS among Hispanic/Latinos. http: //www.cdc.gov/hiv/resources/factsheets/PDF/ hispanic.pdf
53. Centers for Disease Control and Prevention. (2008). HIV and AIDS in the United States: A picture of today's epidemic. http: //cdc.gov/hiv/topics/ surveillance/ united_states.htm
54. Centers for Disease Control and Prevention. Incidence and diagnosis of HIV infection - Puerto Rico, MMWR 2006; 58: 589-591.
55. Colón-López V, Rodriguez-Díaz CE, Ortiz AP, Soto-Salgado M, et al. Epidemiological profile of HIV-related risks among a sample of MSM in Puerto Rico: An overview of substance use and sexual practices. Under Review.
56. Palefsky J. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS 2009;4: 52-56.
57. Joseph DA, Miller JW, Wu X, Chen VW, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008; 113(10 Suppl): 2892-2900.
58. Horner MJ, Ries LA, Krapcho M, Neyman N, et al. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD, http: // seer.cancer.gov/csr/1975 _2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009.
59. Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, et al. Marked increase in the incidence of invasive anal cancer among HIV infected patients despite treatment with combination antiretroviral therapy. AIDS 2008; 22: 1203-1211.
60. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101: 1120-1130.
61. Jemal A, Murray T, Samuels A, Ghafoor A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26.
62. Castro TP, Bussoloti Filho I. Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx. Braz J Otorhinolaryngol 2006;72: 272-282.
63. Herrero R, Castellsagué X, Pawlita M, Lissowska J, et al. Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95: 1772-1783.
64. Oral health U.S. Dental, Oral and Craniofacial Data Resource Center of the National Institute of Dental and Craniofacial Research, the National Institutes of Health and Division of Oral Health, National Center for Chronic Disease Prevention and Health Promotion, the Centers for Disease Control and Prevention. 2002. Available at http: //drc.hhs.gov/ report/pdfs/section6-oralinfections.pdf
65. Kreimer AR, Bhatia RK, Messeguer AL, González P, et al. Oral Human Papillomavirus in Healthy Individuals: A Systematic Review of the Literature. Sex Transm Dis 2010; 37: 386-391.
66. D'Souza G, Agrawal Y, Halpern J, Bodison S, et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009;199: 1263-1269.
67. Heck JE, Berthiller J, Vaccarella S, Winn DM, et al. Sexual behaviours and the risk of head and neck cancers: A pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010;39: 166-181.
68. Cancer Facts & Figures for Hispanics/Latinos 2006-2008. American Cancer Society, 2006. Available at: http: //www.cancer.org/downloads/ STT/CAFF2006Hisp PWSecured.pdf
69. Puerto Rico Central Cancer Registry, Puerto Rico Cancer Incidence File (May 2007), Division of Epidemiology, Puerto Rico Department of Health. Accessed: http: //www.salud.gov.pr/RCancer/Reports/Documents/ Incidencia,%202003.pdf
70. International Agency for Cancer Research GLOBOCAN 2008 database: Table by populations. Lyon, France. Accessed at: http: //globocan.iarc.fr/ summary_table_site.aspselection=13010&selection=21030&title=Lip
71. Suárez E, Calo W, Hernández Y, Diaz-Toro E, et al. Age-standardized incidence and mortality rates of oral and pharyngeal cancer in Puerto Rico and among Non-Hispanics Whites, Non-Hispanics blacks, and Hispanics and in the USA. BMC Cancer 2009; 9: 129.
72. Hennessey PT, Westra WH, Califano JA. Human papillomavirus and head and neck squamous cell carcinoma: Recent evidence and clinical implications. J Dent Res 2009; 88: 300-306.
73. Ryerson AB, Peters ES, Coughlin SS, Chen VW, et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 2008; 113: 2901-2909.
74. Anaya-Saavedra G, Ramírez-Amador V, Irigoyen-Camacho ME, García- Cuellar CM, et al. High association of human papillomavirus infection with oral cancer: A case-control study. Arch Med Res 2008;39: 189-197.
75. Garrote LF, Herrero R, Reyes RM, Vaccarella S, et al. Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer 2001;85: 46-54.
76. Lohavanichbutr P, Houck J, Fan W, Yueh B, et al. Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices. Arch Otolaryngol Head Neck Surg. 2009;135: 180-188.
77. Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: A virus-related cancer epidemic. Lancet Oncol 2010; Epub ahead of print
78. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: An emerging epidemic of human papillomavirus- associated cancers? Cancer 2007;110: 1429-1435
79. Figueroa NR, De la Torre T, Ortiz KJ, Pérez J (eds), et al. Cancer of the Oral Cavity and Pharynx Stat Fact Sheet, Puerto Rico Central Cancer Registry. San Juan, PR, http: //www.salud.gov.pr/RCancer/Reports/ Pages/default.aspx, based on May 2007 Puerto Rico Central Cancer Registry data submission.
80. Franceschi S, Bidoli E, Herrero R, Muñoz N. Comparison of cancers of the oral cavity and pharynx worldwide: Etiological clues. Oral Oncology 2000;36: 106-115.
81. Báez A, Almodóvar JI, Cantor A, Celestin F, et al. High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population. Head Neck 2004; 26: 778-784.
82. Gallegos-Hernández JF, Paredes-Hernández E, Flores-Díaz R, Minauro- Muñoz G, et al. Human papillomavirus: association with head and neck cancer. Cir Cir 2007;75: 151-155.
83. Ibieta BR, Lizano M, Fras-Mendivil M, Barrera JL, et al. Human papilloma virus in oral squamous cell carcinoma in a Mexican population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99: 311-315.
84. Hayes RB, Bravo-Otero E, Kleinman DV, Brown LM, et al. Tobacco and alcohol use and oral cancer in Puerto Rico. Cancer Causes Control 1999;10: 27-33.
85. Baer H, Allen S, Braun L. Knowledge of human papillomavirus infection among young adult men and women: Implications for health education and research. J Commun Health 2000;25: 67-78.
86. Reyes JC. Association between HPV knowledge and high-risk behaviors in Puerto Rico. 2009. Poster session presented at the 25th International Papillomavirus Conference, Malvo Sweden.
87. Fernandez ME, McCurdy SA, Arvey SR, Tyson SK, et al. HPV knowledge, attitudes, and cultural beliefs among Hispanic men and women living on the Texas-Mexico border. Ethn Health 2009;14: 607-624.
88. Fortenberry JD. The effects of stigma on genital herpes care-seeking behaviours. Herpes 2004;11: 8-11.
89. Fortenberry JD, McFarlane M, Bleakley A, Bull S, et al. Relationships of stigma and shame to gonorrhea and HIV screening. Am J Public Health 2002;92: 378-381.
90. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory- informed, systematic review. Prev Med 2007;45: 107-114.
91. Ferris DG, Waller JL, Miller J, Patel P, et al. Variables associated with human papillomavirus (HPV) vaccine acceptance by men. J Am Board Fam Med 2009;22: 34-42.
92. Reiter PL, Brewer NT, Smith JS. HPV Knowledge and HPV Vaccine Acceptability among a National Sample of Heterosexual Males. Sex Transm Infect 2010;86: 241-246.
93. Gerend MA, Barley J. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis 2009;36: 58-62.
94. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory- informed, systematic review. Prev Med 2007;45: 107-114.
95. Podolsky R, Cremer M, Atrio J, Hochman T, Arslan AA. HPV vaccine acceptability by Latino parents: A comparison of U.S. and Salvadoran populations. J Pediatr Adolesc Gynecol. 2009;22: 205-215.
96. Poundstone KE, Strathdee SA, Celentano DD. The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiol Rev 2004;26: 22-35.
97. De La Rosa MR, Khalsa JH, Rouse BA. Hispanics and illicit drug use: A review of recent findings. International Journal of Addiction 1990;25: 665-691.
98. DiClemente RJ, Wingood GM, Harrington KF, Lang DL, et al. Efficacy of an HIV prevention intervention for African American adolescent girls: A randomized controlled trial. JAMA 2004;292: 171-179.
99. Palefsky JM. HPV infection in men. Dis Markers 2007;23: 261-72.